Painful bone metastases: radiation, bone agents and cord compression
Bottom line
External beam radiation is the core treatment for painful bone metastases, and a single 8 Gy fraction relieves pain as well as longer courses. Cord compression needs dexamethasone and urgent surgical and radiation review; bone agents are adjuncts, not analgesics.
Key points
- Radiate painful bone metastases. ASTRO 2024 recommends radiation for pain from bone and spine metastases, with or without cord or cauda equina compression 1.
- Single fraction equals multiple fractions for pain. Acceptable conventional regimens are 8 Gy in 1, 20 Gy in 5, 24 Gy in 6 or 30 Gy in 10 fractions, and pain relief is equivalent between single and multiple fractions 12.
- Choose by the whole person. The regimen should reflect prognosis, prior radiation, normal-tissue risk, quality of life, cost and patient goals, with shared decision-making 1.
- SBRT is for selected patients. It is conditionally recommended over conventional radiation only for good performance status without need for surgery or neurologic signs 1.
- Cord compression: steroids, then surgery plus radiation. Dexamethasone is recommended for spine metastases compressing the cord or cauda equina, and surgery with postoperative radiation is conditionally preferred over radiation alone 1.
- Bone-modifying agents prevent events but barely treat pain. ASCO-CCO recommends them for breast cancer with bone metastases; their analgesic effect is modest, so they should not be used alone for bone pain; analgesics, radiotherapy and supportive care continue 3.
Watch for
Metastatic compression of the spinal cord or cauda equina is not managed with analgesics and observation: give dexamethasone and involve surgery and radiation oncology, since surgery plus radiation is conditionally preferred 1.
High-yield for the exam
- Retreatment of recurrent pain at peripheral or spine sites is safe and effective within published dose constraints 2.
- Surgery, radionuclides, bisphosphonates and vertebral augmentation do not remove the need for external beam radiation 2.
- For surgery-ineligible cord compression, ASTRO lists 8 Gy/1, 16 Gy/2, 20 Gy/5 or 30 Gy/10 1.
- Patients with nonspine bone metastases needing surgery are recommended postoperative radiation 1.
- Evidence is insufficient to prefer one bone-modifying agent over another 3.
- Denosumab is contraindicated in hypocalcemia, which must be corrected first; supplement calcium and vitamin D 4.
- Perform an oral examination before denosumab and avoid invasive dental work because of osteonecrosis of the jaw 4.
Numbers to know
| Item | Value |
|---|---|
| Single-fraction dose | 8 Gy (800 cGy) 1 |
| Multifraction options | 20/5, 24/6, 30/10 Gy/fractions 1 |
| Denosumab | 120 mg SC every 4 weeks 3 |
| Zoledronic acid | 4 mg IV every 12 weeks or every 3–4 weeks 3 |
| Pamidronate | 90 mg IV every 3–4 weeks 3 |
| Spine reirradiation options | 8/1, 20/5, 24/6, 20/8 Gy/fractions 1 |
Common traps
- Assuming longer fractionated courses relieve pain better than a single 8 Gy fraction 2.
- Assuming single fractions are unsafe for spine lesions; high-quality data show acceptable late toxicity 2.
- Relying on a bisphosphonate to treat acute cord compression 13.
- Offering SBRT to a patient with poor performance status 1.
Practise this topic
6 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Alcorn S, et al. External beam radiation therapy for palliation of symptomatic bone metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol, 2024. pubmed.ncbi.nlm.nih.gov/38788923/
- Lutz S, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol, 2017. pubmed.ncbi.nlm.nih.gov/27663933/
- Van Poznak C, et al. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. J Clin Oncol, 2017. pubmed.ncbi.nlm.nih.gov/29035643/
- US Food and Drug Administration. XGEVA (denosumab) injection prescribing information. DailyMed, 2026. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=628f0998-12
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.